Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in...
ImportanceAfter multiple sclerosis (MS) relapse while a patient is receiving an injectable disease-modifying drug, many physicians advocate therapy switch, but the relative effectiveness of different...
View ArticleTreatment Decisions for Patients With Active Multiple Sclerosis
In the complex scenario of current multiple sclerosis (MS) treatment options, it is becoming imperative for clinicians to have the instruments to make prompt treatment decisions for patients who have a...
View ArticleTransglutaminase 6 Antibodies in the Serum of Patients With ALS
This case-control study suggests that an amyotrophic lateral sclerosis syndrome might be associated with autoimmunity and gluten sensitivity.
View ArticleAntibodies to Clustered Acetylcholine Receptors and Myasthenia Gravis
This cohort study determines the diagnostic usefulness of cell-based assays in the diagnosis of myasthenia gravis and compares the clinical features of patients with antibodies only to clustered...
View ArticleUnraveling the Enigma of Seronegative Myasthenia Gravis
Myasthenia gravis (MG) is the prototypic autoimmune neurological disorder. Weakness and muscle fatigue in MG result from an autoimmune attack on the neuromuscular junction, which causes a failure of...
View ArticleParaneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase
This case series study describes the clinical and immunological features of patients with paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies.
View ArticleFeatures and Outcomes of Necrotizing Autoimmune Myopathy
This medical record review study of patients with necrotizing autoimmune myopathy describes characteristics of the disease and determines clinical outcome predictors.
View ArticleThe Clinical Spectrum of Necrotizing Autoimmune Myopathy
Necrotizing autoimmune myopathy (NAM) is a recently defined subcategory of the acquired idiopathic myopathies, characterized clinically by the subacute onset of proximal weakness, elevated creatine...
View ArticleEncephalitis Associated With Antibodies Against the AMPA Receptor
This case series describes 7 patients with encephalitis with antibodies against the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor and provides a review of the literature on this disease...
View ArticleParaneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase
This case series study describes the clinical and immunological features of patients with paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies.
View ArticleFeatures and Outcomes of Necrotizing Autoimmune Myopathy
This medical record review study of patients with necrotizing autoimmune myopathy describes characteristics of the disease and determines clinical outcome predictors.
View ArticleThe Clinical Spectrum of Necrotizing Autoimmune Myopathy
Necrotizing autoimmune myopathy (NAM) is a recently defined subcategory of the acquired idiopathic myopathies, characterized clinically by the subacute onset of proximal weakness, elevated creatine...
View ArticleRituximab Therapy in Neuromyelitis Optica
Neuromyelitis optica (NMO) spectrum disorders represent an evolving group of central nervous system–inflammatory autoimmune demyelinating diseases unified by a pathogenic autoantibody specific for the...
View ArticleAutoimmune Cerebellar Ataxia Accompanying Neural Antibodies in Adults
This cohort study reports the treatment and outcome experience of a single clinic in a population of adults with autoimmune cerebellar ataxia.
View ArticleNovel Variant of Miller Fisher Syndrome
This case report describes a 43-year-old woman who presented to an acute medical team with a 3-day history of worsening diplopia.
View ArticleMultiple Sclerosis Disease-Modifying Therapy Effects
This review examines the effects of multiple sclerosis disease-modifying therapies on B-cell immunity.
View ArticleEffects of Metformin and Pioglitazone in Metabolic Syndrome and MS
This cohort study evaluates the effects of metformin and pioglitazone on immune regulation in patients with multiple sclerosis and metabolic syndrome and evaluates potential mechanisms underlying this...
View ArticleStiff-Person Spectrum Disorder Investigations
This case-series study reports the clinical and immunologic findings in a cohort of patients with stiff-person spectrum disorder, including stiff-person syndrome, stiff-limb syndrome, or stiff-person...
View ArticleHematopoietic Stem Cell Transplantation–Treated Myasthenia Gravis
This study reports 7 cases of severe myasthenia gravis treated with autologous hematopoietic stem cell transplant in which consistent, durable, symptom-free, and treatment-free remission was achieved.
View ArticleAlemtuzumab and Multiple Sclerosis
Alemtuzumab is a humanized monoclonal antibody that binds to CD52, a surface molecule expressed by many types of immune cells, including T lymphocytes, B lymphocytes, monocytes, macrophages, and...
View Article